Studies
Uniquity One NSI-8226-201 EE (ALAMERE)
Internal Medicine
Immunology
Gastroenterology
Esophagitis
Digestive Disease
Adult Subjects
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis.